학술논문
Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung Cancer
Document Type
Article
Source
In Clinical Lung Cancer December 2022 23(8):731-736
Subject
Language
ISSN
1525-7304